Shopping Cart
Remove All
Your shopping cart is currently empty
Retinestatin is a novel polyol polyketide compound that protects SH-SY5Y dopaminergic cells from MPP+-induced cytotoxicity. It demonstrates neuroprotective effects in in vitro models of Parkinson's disease.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Retinestatin is a novel polyol polyketide compound that protects SH-SY5Y dopaminergic cells from MPP+-induced cytotoxicity. It demonstrates neuroprotective effects in in vitro models of Parkinson's disease. |
| In vitro | Retinestatin (10 μM; pretreated for 24 hours) significantly reduces MPP+ (2 mM; 24 hours) induced cytotoxicity in SH-SY5Y dopaminergic neurons. Additionally, Retinestatin (10 μM; pretreated for 24 hours) rescues the downregulation of Bcl-xL and the upregulation of Bak induced by MPP+. |
| Formula | C25H40O12 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.